Dr. Daniels is a seasoned biotechnology executive with more than two decades of experience spanning clinical development, regulatory strategy, corporate operations, and business development. He most ...

Idorsia thanks Alberto Gimona - most recently Head of Global Clinical Development and Medical Affairs - and wishes him all the best for a well-deserved retirementAmer Joseph joins Idorsia as EVP, Chie ...

Nearly seven years after the FDA approved Novo Nordisk’s Ozempic for diabetes treatment, this medication and other GLP-1 receptor agonists have proven very effective in promoting weight loss. For the ...

Over the past several years, pharmaceutical companies have been steadily integrating artificial intelligence (AI) into many aspects of clinical development. Today, AI’s impact is being felt from the ...

The partnership will combine Daiichi Sankyo’s clinical trial and preclinical research data with Tempus’ real-world data.

Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in ...

Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, outlines future steps for the clinical development of rilzabrutinib, as well as promising data to advance to phase 3 studies ...

When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

A Türkiye-originated oncology drug candidate, RS-0139, has successfully completed its Phase 1 clinical trial, positioning itself as a key milestone in ...

This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...

An analysis of 65,061 globally recruiting clinical trials across 186 countries finds that 4,361 studies, equivalent to 6.7% ...